Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study

doi:10.1186/ar2740

Download references

Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study

Jacques Tebib^*, Xavier Mariette, Pierre Bourgeois, René-Marc Flipo, Philippe Gaudin, Xavier Le Loët, Paul Gineste, Laurent Guy, Colin D Mansfield, Alain Moussy, Patrice Dubreuil, Olivier Hermine^* and Jean Sibilia

* Corresponding authors: Jacques Tebib jacques.tebib@chu-lyon.fr - Olivier Hermine ohermine@gmail.com

Arthritis Research & Therapy 2009, 11:R95 doi:10.1186/ar2740

Include	Article citation and all cited references Cited references only Article citation only
Format	EndNote, Zotero or Papers Reference Manager Refworks BibTeX

Arthritis Research & Therapy

Viewing options

Associated material

Tools

Download references

Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study

Arthritis Research & Therapy

Viewing options

Associated material

Related literature

Cited by

Other articles by authors

Related articles/pages

Tools

Download references

Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study